Ifosfamide-pharmacology, safety and therapeutic potential
- 1 March 1985
- journal article
- clinical trial
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 12 (1), 1-47
- https://doi.org/10.1016/0305-7372(85)90011-8
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)European Journal of Cancer and Clinical Oncology, 1982
- Etoposide and etoposide-ifosfamide therapy for refractory testicular tumorsCancer Treatment Reviews, 1982
- Chemotherapie maligner Melanome mit cis-Diamino-dichloroplatinum und IfosfamidDeutsche Medizinische Wochenschrift (1946), 1982
- Kombinationschemotherapie maligner Melanome mit cis-Diamino-dichloro-platin (II) und IfosfamidKlinische Wochenschrift, 1981
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—IEuropean Journal of Cancer (1965), 1981
- Chemotherapeutische Behandlungsmöglichkeiten bei fortgeschrittenen SarkomenDeutsche Medizinische Wochenschrift (1946), 1981
- Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanomaZeitschrift für Krebsforschung und Klinische Onkologie, 1980
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- Pharmacokinetics of ifosfamideClinical Pharmacology & Therapeutics, 1975